|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-5-10
|
|
pubmed:abstractText |
This study was performed to investigate the impact of HAART versus no HAART and nucleoside free versus nucleoside containing HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV/HCV co-infected patients. In addition a control group of HCV mono-infected patients undergoing anti-HCV therapy was evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0949-2321
|
|
pubmed:author |
pubmed-author:AhlenstielGG,
pubmed-author:BaumgartenAA,
pubmed-author:BickelMM,
pubmed-author:BuggischPP,
pubmed-author:FenskeSS,
pubmed-author:GölzJJ,
pubmed-author:HintscheBB,
pubmed-author:JohnCC,
pubmed-author:KhaykinPP,
pubmed-author:KlinkerHH,
pubmed-author:LutzTT,
pubmed-author:MayoDD,
pubmed-author:RockstrohJ KJK,
pubmed-author:SchürmannDD,
pubmed-author:StaszewskiSS,
pubmed-author:StephanCC,
pubmed-author:TreipCC,
pubmed-author:VogelMM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
102-11
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20452894-Adult,
pubmed-meshheading:20452894-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:20452894-Antiviral Agents,
pubmed-meshheading:20452894-Case-Control Studies,
pubmed-meshheading:20452894-Drug Carriers,
pubmed-meshheading:20452894-Drug Therapy, Combination,
pubmed-meshheading:20452894-Female,
pubmed-meshheading:20452894-HIV Infections,
pubmed-meshheading:20452894-Hepacivirus,
pubmed-meshheading:20452894-Hepatitis C, Chronic,
pubmed-meshheading:20452894-Humans,
pubmed-meshheading:20452894-Interferon-alpha,
pubmed-meshheading:20452894-Male,
pubmed-meshheading:20452894-Middle Aged,
pubmed-meshheading:20452894-Polyethylene Glycols,
pubmed-meshheading:20452894-Prospective Studies,
pubmed-meshheading:20452894-Recombinant Proteins,
pubmed-meshheading:20452894-Ribavirin,
pubmed-meshheading:20452894-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Rheinische friedrich-Wilhelms-University, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
